2002
DOI: 10.1097/00002030-200201040-00010
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy

Abstract: Many physicians delay HAART in patients presenting with TB because of pill burden, drug/drug interactions and toxicity. Although the use of HAART led to significant reductions in viral load, ADI and mortality, co-infected patients commonly experienced AE leading to interruptions in TB/HIV therapy. We therefore recommend starting HAART early for patients with advanced HIV disease (CD4 < 100 x 106 cells/l) and deferring HAART until the continuation phase of TB therapy (i.e. after 2 months) for patients who are c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

16
222
6
16

Year Published

2003
2003
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 285 publications
(260 citation statements)
references
References 25 publications
16
222
6
16
Order By: Relevance
“…Previous epidemiologic studies in Thailand and other countries have demonstrated marked improvement in duration of survival among HIV-infected TB patients treated with ART during TB treatment (2,7,16,(36)(37)(38). Our study confi rms this fi nding and suggests that ART use most likely would dramatically reduce both early and late deaths.…”
Section: Discussionsupporting
confidence: 84%
“…Previous epidemiologic studies in Thailand and other countries have demonstrated marked improvement in duration of survival among HIV-infected TB patients treated with ART during TB treatment (2,7,16,(36)(37)(38). Our study confi rms this fi nding and suggests that ART use most likely would dramatically reduce both early and late deaths.…”
Section: Discussionsupporting
confidence: 84%
“…Several studies have demonstrated the impact of highly active antiretroviral therapy (HAART) on HIV-infected patients; these treatments have been successful in restoring immune function and reducing morbidity and mortality [10,27,28,29,30,31]. The use of antiretroviral therapy (ART) in these patients reduces the risk of developing active TB [32,33,34], being associated in HIV-infected TB patients with higher rates of survival, when used during and after TB treatment [25,27,35].…”
Section: Discussionmentioning
confidence: 99%
“…IRIS is common among HIV-infected patients and co-infected with MAC, Mycobacterium tuberculosis or other pathogens. Diagnosis of IRIS is difficult for clinicians; differential diagnosis includes treatment failure or resistance and other opportunistic diseases 4,13 .…”
Section: Discussionmentioning
confidence: 99%